Want to join the conversation?
$WBA's 4Q15 total sales for the Retail Pharmacy USA division were $19.9Bil, an increase of 4.7% over 4Q14. Total sales in comparable drugstores increased 6.5% compared with the same quarter a year ago. Further during the quarter gross profit was $5.3Bil with an SG&A of $4.7Bil resulting in operating income of $511MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.